AbbVie Stock Jumps After Q2 Earnings – Here’s Why
AbbVie Inc (NYSE: ABBV) delivered its Q2 earnings report with noteworthy figures, showing resilience amid challenging conditions. Adjusted EPS for the quarter stood at $2.91, which, despite being down 13.6% year-over-year, surpassed the consensus estimate of $2.80. The company’s overall sales experienced a decline of 4.9% year-over-year (or 4.2% on an operational basis), totaling $13.87…